YIJIAYI
Yijiayi have treatment methods for cancer patients such as surgery, radiotherapy, and chemotherapy can result in toxic and side effects such as dry mouth, nausea and vomiting, diarrhea, and constipation, as psychological factors such as depression and anxiety, which can affect the patient's appetite and eating habits of nutritional deficiencies in cancer patients.
YIJIAYI
Industry:
Health Care Internet Medical
Founded:
2014-05-30
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.iplusmed.com
Total Employee:
101+
Status:
Active
Contact:
400-005-9900
Total Funding:
15 M CNY
Technology used in webpage:
Domain Not Resolving Euro CrUX Top 50m CrUX Dataset Pound Sterling Japanese Yen Apache 2.4 Ubuntu Baidu Maps Alibaba Cloud CDN
Similar Organizations
Bainbridge Health
Bainbridge Health provides hospital systems with a clinical intelligence and data analytics platform to improve medication safety.
myTomorrows
myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Taiwan Global Angels
Taiwan Global Angels (TGA) is a global network of seasoned angel investors primarily based in the US and Taiwan.
VitalTrax
VitalTrax connects patients with clinical trials with its cloud-based clinical trial network.
Investors List
Tigermed
Tigermed investment in Series A - Yijiayi
GP Capital
GP Capital investment in Series A - Yijiayi
Zhongwei Jijin
Zhongwei Jijin investment in Series A - Yijiayi
Official Site Inspections
http://www.iplusmed.com Semrush global rank: 1.57 M Semrush visits lastest month: 15.1 K
- Host name: 121.199.38.221
- IP address: 121.199.38.221
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Yijiayi"
i+med | technologia medyczna - iplusmed.eu
Nov 20, 2019 mail: info@iplusmed.eu tel. +48 58 554 81 96. NIP 5842767638 REGON 369379338 KRS 0000716719. Join us on social media. Follow; Follow; Follow; Human – …See details»
i+med | technologia medyczna
Od wielu lat Iplusmed jest liczącym się na arenie europejskiej podmiotem dostrzegającym wagę tego zagadnienia, który w tworzonych przez siebie projektach technologii medycznej …See details»
iPlusMed 2025 Company Profile: Valuation, Funding & Investors
IPlusMed General Information Description. Developer of a medical app for oncology patients. The company focuses on alleviating pain points for cancer patients who are looking for suitable …See details»
易加医-肿瘤问题,一站解决,专属肿瘤患者的互联网医疗服务平台
Apr 14, 2025 全国公立医院将取消门诊预交金，肿瘤患者就医更轻松 2025-04-10 国家卫健委等部门宣布自2025年起全国公立医疗机构取消门诊预交金并降低住院预交金，旨在优化医疗服务 …See details»
iplusmed - Products, Competitors, Financials, Employees, …
Iplusmed is a company operating within the healthcare sector that provides telemedicine services for cancer patients. Use the CB Insights Platform to explore iplusmed's full profile. iplusmed - …See details»
Iplusmed - LinkedIn
📅 Już w ten czwartek, 24 października, Iplusmed weźmie udział w 2. odsłonie konferencji „Medycyna w Architekturze”, której hasłem przewodnim jest Evidence Based Design (EBD), czyli ...See details»
Conference of the Association of Health Care Managers and the …
Last year, Iplusmed together with Industria Project established an organizational unit employing engineers specializing in energy consulting. Iplusmed, together with its partner Fibrain group, …See details»
iPlusMed - Headquarter Location, Corporate Office Address and …
IPlusMed is Decision/Risk Analysis in China that focus on developer business. Founded in 2014. They cover business area such as developer, oncology patient, pain point, cancer patient, …See details»
加入我们_易加医新闻 - 易加医 - iplusmed.com
易加医,国内知名肿瘤领域的互联网医患平台.目前企业招聘产品运营、客服、医学专员、销售等岗位,期待您的加入!See details»
Yijiayi - Crunchbase Company Profile & Funding
Yijiayi have treatment methods for cancer patients such as surgery, radiotherapy, and chemotherapy can result in toxic and side effects such as dry mouth, nausea and vomiting, …See details»
Truth About Iplusmed. Is Iplusmed the Right Choice?
Read reviews of Iplusmed. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. Categories Log in For business. Categories. …See details»
易加医-肿瘤问题,一站解决,专属肿瘤患者的互联网医疗服务平台
Apr 17, 2024 易加医是一个专注于为肿瘤患者提供一站式服务的互联网平台.服务涵盖精准就医,远程会诊,海外就医,私人医生,肿瘤康复,新药搜寻,临床研究资讯等.为肿瘤患者和家属提供专业服 …See details»
i+med | technologia medyczna - iplusmed.eu
Iplusmed bei der Feier zum 20-jährigen Jubiläum des Polnischen Verbandes der Privatkrankenhäuser Okt. 7, 2022 In Gdynia feierte der Polnische Verband der …See details»
aktualnosc-EN | i+med - iplusmed.eu
On March 30, representatives of Iplusmed were present at the conference of the Association of Health Care Managers and the National Medical Review devoted to the issues of modern …See details»
肿瘤远程会诊平台,易加医让"肿瘤患者"足不出户享受顶 …
Sep 18, 2019 易加医www.iplusmed.com - 防癌、抗癌、肿瘤癌症找医生,国内知名的肿瘤医患平台 返回搜狐，查看更多 责任编辑： 平台声明：该文观点仅代表作者本人，搜狐号系信息发布 …See details»
易加医-肿瘤问题,一站解决,专属肿瘤患者的互联网医疗服务平台
易加医-肿瘤问题,一站解决,专属肿瘤患者的互联网医疗服务平台See details»
肿瘤资讯_癌症最新消息_肿瘤患者学习必备 - 易加医
肿瘤临床参加：erbb2基因突变免费用靶向药的临床研究 2025-01-15 现正在开展一项不限癌种的erbb2基因突变靶向药的临床研究，入组后均免费用药和检查: 队列组: 1.结直肠癌 2.胆道癌 3. …See details»
Hospital | i+med - iplusmed.eu
The first stage of the expansion of the Independent Public Health Care Facility, assuming the expansion of the emergency room with a new building and its reconstruction in the existing …See details»
易加医-动脉网 - vbdata.cn
May 30, 2014 易加医是国内首个专注于肿瘤领域的互联网医患平台，是行业内最具影响力的肿瘤领域互联网医疗项目之一。服务涵盖肿瘤预防、就医、诊疗、康复的全程，为肿瘤患者和家属 …See details»
易加医-肿瘤问题,一站解决,专属肿瘤患者的互联网医疗服务平台
八天五地，精彩在即---2020年，csco学术年会欢迎您！ 八天五地，精彩在即---2020年，csco学术年会欢迎您！ 由中国临床肿瘤学会（csco）、北京市希思科临床肿瘤学研究基金会和国家癌 …See details»